ALPS Medical Breakthroughs ETF
SBIO NYSE Arca
The Fund seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index. The ALPS Medical Breakthroughs ETF invests in the public equity markets of the United States. It invests in the stocks of com...
Hover to inspectDrag to measure a move← → to step through days
- Fund size
- 216M as of Feb 2020
- Expense ratio
- 0.50% per year
- Dividend yield
- 0.00% Yearly
- Volatility · 1Y
- 31.8% High Risk
- Beta
- 0.99 vs the market
- 52-week range
- 41.0870.79
How SBIO has paid off
Price return over every period, and total return with dividends reinvested, set against price alone.
Return by period
Price · to Oct 12Total return vs price return
Price onlyOver 1 year, SBIO returned +30.6% with dividends reinvested — dividends added 0.0 pts to the price move.
How bumpy is the ride?
Return only means something next to the risk taken to earn it. Volatility, drawdowns and market sensitivity over 1 year.
Volatility
Annualized · 1YA typical year sees the price swing about ±32% around its trend.
Drawdown from peak
How far below its previous high the price has been Deepest fall −23.9% on Oct 12, 2026 — 54 days after the previous high
More than 5% below a high 43% of the time.
Market sensitivity
BetaA beta of 0.99 means SBIO has moved roughly in line with the market.
Trend & momentum
Where the price sits against its moving averages, and how stretched the recent move is.
Price vs moving averages
Uptrend- 12-day average56.21 −4.2%
- 26-day average59.03 −8.8%
- 50-day average61.01 −11.7%
- 200-day average56.50 −4.7%
The price is above 0 of 4 averages. The 50-day average is above the 200-day, a sign of a rising longer-term trend.
Relative strength (RSI)
OversoldRSI compares recent gains with recent losses on a 0–100 scale. Above 70 a move is often considered stretched, below 30 washed out.
Technical indicators describe past prices. They are not a forecast.
Inside the fund
Health Care · Research Advancement — tracking the S-Network Medical Breakthroughs Index.
- Assets under management216MUSD
- Expense ratio0.50%per year
- Holdings71
- Risk score5.7Medium
Launched December 2014. Listed options available. Fund data as of Feb 28, 2020.
Where SBIO shows up
Curated themes and indices that hold SBIO. Open one to see it in context, or test the whole theme in a portfolio.
About ALPS Medical Breakthroughs ETF
The Fund seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index. The ALPS Medical Breakthroughs ETF invests in the public equity markets of the United States. It invests in the stocks of companies operating in the biotechnology and pharmaceutical sectors. The fund invests in stocks of mid cap and small cap companies with a market capitalization of no less than $200 million and no more than $5 billion
- Featured in 4 curated themes
- 71 holdings
- Ticker
- SBIO
- Exchange
- NYSE Arca
- ISIN
- US00162Q5936
- CUSIP
- 00162Q593
- Currency
- U.S. Dollar (USD)
- Country
- USA
- Sector
- Health Care
- Industry
- Research Advancement
- Benchmark
- S-Network Medical Breakthroughs Index
All key statistics
Details
Shareas of Oct 12, 2026
Dataas of Feb 28, 2020
Put SBIO to the test
See how it would change the return and the risk of a portfolio, with virtual money, before a single real dollar moves.
Data for information only, not investment advice. Past performance does not guarantee future results.